In the French trial, more cardiovascular-related deaths were also observed; our SA-1 showed a larger risk of cardiovascular-related deaths in the IGRT arm, but this did not reach statistical significance (HR = 2.39; 95% CI, 0.63–9.03; p = 0.20).
← all excerpts
Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.
1
0.2000
0.2000